Creating a new treatment using exosomes from organoids for osteoarthritis
Official title: Development of an Organoid-Derived Exosome Product for the Treatment of Osteoarthritis
Funded at University of Minnesota · NIH-10888061 · Data updated 2026-11-12
This study is exploring a new treatment for osteoarthritis using tiny particles called exosomes from special lab-grown tissues, which might help reduce inflammation and repair cartilage, aiming to find the best way to make these particles work for people with this painful condition.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project start | August 15, 2024 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $426,250 |
| NIH project number | 1R21AG083324-01A1 |
| Project ID | NIH-10888061 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with osteoarthritis, particularly those experiencing significant joint pain and inflammation.
✕Less likely to help
Patients with osteoarthritis who are not experiencing inflammation or those with advanced joint degeneration may not benefit from this research.
What this research studies
This research focuses on developing a novel treatment for osteoarthritis (OA) by utilizing exosomes derived from multi-tissue organoids. These exosomes are believed to have immunoregulatory properties that can help reduce inflammation and promote cartilage repair. The study aims to identify the optimal stage of organoid development to maximize the therapeutic effects of these exosomes. By targeting the underlying inflammation associated with OA, this approach seeks to provide a more effective treatment option for patients suffering from this debilitating condition.
Why it matters
Potential benefit: If successful, this research could lead to a groundbreaking therapy that not only alleviates symptoms of osteoarthritis but also slows its progression.
How similar studies have gone: While the use of exosomes in treating osteoarthritis is a relatively novel approach, preliminary studies have shown promise in similar applications, indicating potential for success.
Where this research is happening
-
University of Minnesota
Minneapolis, United States Active
Researchers
- Principal investigator: Ramachandran, Sabarinathan — University of Minnesota
- Study coordinator: Ramachandran, Sabarinathan
Related research
Other NIH-funded projects on the same topics.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Identifying OA subtypes and early warning signs before joint damage
This grant asks researchers to find early, invisible clues of osteoarthritis subtypes so we can target treatments before joints are damaged.
-
Digital biomarkers to guide personalized rehab after ACL injury
Aims to use wearable sensors and phone videos to predict early osteoarthritis risk after ACL surgery so rehabilitation can be tailored to each patient.
-
Aberrant mechano-oxygen coupling linked to zinc-rich mineralization in osteoarthritis
Aims to understand how abnormal joint forces affect cartilage and bone, causing zinc-rich mineral deposits and harmful blood vessel growth in osteoarthritis.
-
Notch signaling in TMJ osteoarthritis: uncovering mechanisms and new targets
Researchers are studying how Notch signaling affects TMJ osteoarthritis to identify new ways to protect and repair the jaw joint.
-
Nanoparticles delivering an sPLA2 blocker for knee osteoarthritis
This project uses tiny, drug-filled nanoparticles to deliver an sPLA2-blocking medicine into the knee to reduce inflammation and slow knee osteoarthritis in people with painful knee OA.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.